The goal of this clinical trial is to evaluate whether a trauma-informed, artificial intelligence-supported chatbot can reduce psychological distress and unmet psychosocial needs in adults newly diagnosed with cancer.:
* Does the chatbot reduce trauma-related distress and anxiety levels compared to standard care?
* Does the chatbot decrease unmet psychosocial needs in patients following a new cancer diagnosis? Researchers will compare the chatbot intervention to standard care to determine whether the chatbot provides additional psychosocial benefit.
Participants will:
* Be randomly assigned to either the chatbot intervention group or the standard care group
* Use the chatbot freely for 12 weeks (intervention group only)
* Complete questionnaires at baseline, 1 month, and 3 months
* Be monitored for any psychological risk indicators during the study period